Bervin Investment & Leasing Limited announced that the Board of directors of the Company in their meeting held on September 30, 2022 has approved; appointment of Mr. Alok Saklani as an Additional Director in the capacity of Non-Executive Independent Director of the Company for a term of 5 years with effect from September 30, 2022 till September 29, 2027. and approved appointment of Mr. Vivek Manohar Padgaonkar as an Additional Director in the capacity of Non-Executive Independent Director of the Company for a term of 5 years with effect from September 30, 2022 till September 29, 2027. Mr. Alok Saklani is an advisor and consultant to organizations in Management Education sector.

He is on the Advisory Board of various Institutions/Universities. A Member of Editorial Boards of various Academic Journals both in India & overseas, Dr Saklani is an established researcher in the fields of General Management, Marketing, Customer Protection, CRM, Satisfaction,& Research Methodology, as well as, Anthropological Parapsychology. He is a post-graduate in Business Studies holding a Doctorate in Finance area from Hemvati Nandan Bahuguna Garhwal University, Srinagar, Uttarakhand.

He has undergone several advanced training programs through the 80s/90s including one on Advanced Data Analysis from IIM-Ahmedabad. Term of Appointment: For a term of 5 years with effect from September 30, 2022 till September 29, 2027; subject to approval of shareholders in the ensuing General Meeting of the Company. Brief profile of Mr. Vivek Padgaonkar; Mr. Vivek Padgaonkar is an advisor and consultant to MNCs and Indian companies in pharma and medical devices sector in the areas of Pricing-DoP/NPPA & Regulatory matters- CDSCO /IPC.

He is also an esteemed Council Member (Knowledge as a service-KaaS), industry outreach consultant at WRCB IIT Mumbai, member of Academic Advisory Council - Goa Institute of Management (Goa) and Welingkar Management Institute (Mumbai). He has been a visiting /Guest faculty on IIM Kolkatta and Trichy and other reputed management institutes in the country. He is a senior leadership professional having vast experience of over four decades with reputed pharmaceuticals organizations (MNC and domestic) and industry associations and exposure in heading and managing business.

He has substantial exposure in lobbying/think-tank organizations on Healthcare issues with the Indian government and made significant contribution in shaping current pharma policies particularly NPPP 2012, DPCO 2013 and UCPMP. Mr. Vivek Padgaonkar is a post-graduate in Science, and holds a Diploma in Management Studies from Mumbai University. He was a topper at diploma in Training & Development from Indian Society for Training & Development (ISTD) and Professional Selling Skills (Train the Trainer) from Learning International USA.

He is the winner of the Mumbai University's Watumull Foundation Award for PG Students as well as Kulapati K.M. Munshi Award. Term of Appointment: For a term of 5 years with effect from September 30, 2022 till September 29, 2027; subject to approval of shareholders in the ensuing General Meeting of the Company.